Cargando…

Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams

INTRODUCTION: Several reports have shown marked heterogeneity of antibiotic pharmacokinetics (PK) in patients admitted to ICUs, which might potentially affect outcomes. Therefore, the pharmacodynamic (PD) parameter of the efficacy of β-lactam antibiotics, that is, the time that its concentration is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonçalves-Pereira, Joao, Póvoa, Pedro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334750/ https://www.ncbi.nlm.nih.gov/pubmed/21914174 http://dx.doi.org/10.1186/cc10441

Ejemplares similares

Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients
por: Goncalves-Pereira, João, et al.
Publicado: (2014)

Pharmacokinetics–pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients
por: Veiga, Rui Pedro, et al.
Publicado: (2018)

Evaluation of gentamicin first-dose pharmacokinetics in septic critically ill patients: pilot study
por: Pereira, JC Gonçalves, et al.
Publicado: (2009)

Optimizing Antimicrobial Drug Dosing in Critically Ill Patients
por: Póvoa, Pedro, et al.
Publicado: (2021)

Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review
por: Póvoa, Pedro, et al.
Publicado: (2012)

Beta-lactam antibiotics in continuous infusion in critically ill patients
por: Jeurissen, Axel, et al.
Publicado: (2010)

Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review
por: Sime, Fekade Bruck, et al.
Publicado: (2012)

β-Lactam Dosing in Critical Patients: A Narrative Review of Optimal Efficacy and the Prevention of Resistance and Toxicity
por: Pereira, João Gonçalves, et al.
Publicado: (2022)

Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis
por: Pai Mangalore, Rekha, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients
por: Han, Ruiying, et al.
Publicado: (2021)

Broad-spectrum β-lactams in obese non-critically ill patients
por: Hites, M, et al.
Publicado: (2014)

607. Establishing Pharmacokinetic Profile of β -lactams in Critically Ill Patients on Continuous Sustained Low-efficiency Dialysis (C-SLED) 
por: Shah, Madiha, et al.
Publicado: (2022)

Update on Therapeutic Drug Monitoring of Beta-Lactam Antibiotics in Critically Ill Patients—A Narrative Review
por: Stašek, Jan, et al.
Publicado: (2023)

β-Lactam Antibiotics Renaissance
por: Qin, Wenling, et al.
Publicado: (2014)

Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation
por: Bakdach, Dana, et al.
Publicado: (2022)

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
por: Luci, Giacomo, et al.
Publicado: (2021)

Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?
por: Van Herendael, Bruno, et al.
Publicado: (2012)

Time Above All Else: Pharmacodynamic Analysis of Β-Lactams in Critically Ill Patients
por: Landmesser, Katherine, et al.
Publicado: (2021)

Dose optimization of β-lactams antibiotics in pediatrics and adults: A systematic review
por: Haseeb, Abdul, et al.
Publicado: (2022)

Occupational allergy to β-lactam antibiotics
por: Classen, Anna, et al.
Publicado: (2015)

Hypersensitivity to non-β-lactam antibiotics
por: Merk, Hans F., et al.
Publicado: (2022)

Structural Insights for β-Lactam Antibiotics
por: Kim, Dogyeoung, et al.
Publicado: (2023)

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature
por: Hartman, Stan J. F., et al.
Publicado: (2019)

Impact of an Extended Infusion Β-lactam Strategy on Outcomes in Critically Ill Patients with Pseudomonas Infections
por: Klinker, Kenneth, et al.
Publicado: (2017)

Continuous Infusion of Piperacillin/Tazobactam in Septic Critically Ill Patients—A Multicenter Propensity Matched Analysis
por: Gonçalves-Pereira, João, et al.
Publicado: (2012)

Addition of probenecid to oral β-lactam antibiotics: a systematic review and meta-analysis
por: Wilson, Richard C, et al.
Publicado: (2022)

β-lactam precision dosing in critically ill children: Current state and knowledge gaps
por: Tang Girdwood, Sonya, et al.
Publicado: (2022)

Pharmacokinetics and pharmacodynamics of antibiotics in critically ill acute kidney injury patients
por: Zamoner, Welder, et al.
Publicado: (2016)

Stability of β-lactam antibiotics in bacterial growth media
por: Brouwers, Rebecca, et al.
Publicado: (2020)

Clinical course and outcomes of critically ill patients with COVID-19 infection: a systematic review
por: Serafim, Rodrigo B., et al.
Publicado: (2021)

BADAN-conjugated β-lactamases as biosensors for β-lactam antibiotic detection
por: Au, Ho-Wah, et al.
Publicado: (2020)

High Serum β-Lactams Specific/Total IgE Ratio Is Associated with Immediate Reactions to β-Lactams Antibiotics
por: Vultaggio, Alessandra, et al.
Publicado: (2015)

Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future
por: Smith, Paul W., et al.
Publicado: (2018)

Repurposing of the β-Lactam Antibiotic, Ceftriaxone for Neurological Disorders: A Review
por: Yimer, Ebrahim M., et al.
Publicado: (2019)

Continuous beta-lactam infusion in critically ill patients: the clinical evidence
por: Abdul-Aziz, Mohd H, et al.
Publicado: (2012)

Outer membrane vesicles from β-lactam-resistant Escherichia coli enable the survival of β-lactam-susceptible E. coli in the presence of β-lactam antibiotics
por: Kim, Si Won, et al.
Publicado: (2018)

Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review
por: Akunne, Onyinye Onyeka, et al.
Publicado: (2021)

Pitfalls in the Immunochemical Determination of β-Lactam Antibiotics in Water
por: Ecke, Alexander, et al.
Publicado: (2021)

Could β-Lactam Antibiotics Block Humoral Immunity?
por: Melenotte, Cléa, et al.
Publicado: (2021)

Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics
por: Cohen, Keira A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l129mre4s8ve7li744odu96s6r